Cystatin C is associated with adverse COVID-19 outcomes in diverse populations

Altmetric

Kleeman, Sam O, Cordioli, Mattia, Timmers, Paul RHJ, Khan, Atlas, Tober-Lau, Pinkus, Kurth, Florian, Demichev, Vadim, Meyer, Hannah V, Wilson, James F, Ralser, Markus, Kiryluk, Krzysztof, Ganna, Andrea, Baillie, Kenneth, Janowitz, Tobias (October 2022) Cystatin C is associated with adverse COVID-19 outcomes in diverse populations. iScience, 25 (10). p. 105040. ISSN 2589-0042 (In Press)

PDF
2022-Janowitz-Cystatin-C-is-associated-with-adverse-covid-19-outcomes-in-diverse-populations.pdf
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (2MB)

DOI: 10.1016/j.isci.2022.105040

Item Type:	Paper
Subjects:	diseases & disorders > viral diseases > coronavirus > covid 19
CSHL Authors:	Kleeman, Sam Meyer, Hannah V. Janowitz, Tobias
Communities:	CSHL labs > Janowitz lab CSHL labs > Meyer Lab
SWORD Depositor:	CSHL Elements
Depositing User:	CSHL Elements
Date:	October 2022
Date Deposited:	15 Sep 2022 21:23
Last Modified:	10 Oct 2022 14:03
PMCID:	PMC9428108
URI:	https://repository.cshl.edu/id/eprint/40719

Actions (login required)

Administrator's edit/view item